CVS and Other Healthcare Stocks Are Soaring. Why the Sector Is No Longer Sick.
Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...
en.etemaaddaily35m
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
According to Novo Nordisk, over 40% of persons with type 2 diabetes have chronic renal disease, which affects roughly 37 ...